β¨ Medicines Approval Notices
21 OCTOBER 2010 NEW ZEALAND GAZETTE, No. 143
Product: Cefuroxime-AFT
Active Ingredient: Cefuroxime sodium 826mg equivalent to 750mg cefuroxime
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medochemie Limited, Limassol, Cyprus
Product: Cefuroxime-AFT
Active Ingredient: Cefuroxime sodium 1652mg equivalent to 1500mg cefuroxime
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medochemie Limited, Limassol, Cyprus
Product: Cipflox
Active Ingredient: Ciprofloxacin 2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Maco Productions SAS, Mouvaux, France
Product: Loperamide Relief
Active Ingredient: Loperamide hydrochloride 2mg
Dosage Form: Capsule
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Adcock Ingram Limited - A Medreich Group Company, Bangalore, India
Product: Nevirapine Alphapharm
Active Ingredient: Nevirapine 200mg
Dosage Form: Tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Matrix Laboratories Limited, Nashik, India
Product: Noraped
Active Ingredient: Noradrenaline acid tartrate monohydrate 8mg
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Haupt Pharma Livron, Livron sur Drome, France
Product: Onglyza
Active Ingredient: Saxagliptin 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: Bristol-Myers Squibb Company, Indiana, United States of America
Product: Pravastatin
Active Ingredient: Pravastatin sodium 10mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra, India
Product: Pravastatin
Active Ingredient: Pravastatin sodium 20mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra, India
Product: Pravastatin
Active Ingredient: Pravastatin sodium 40mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra, India
Product: Rizamelt
Active Ingredient: Rizatriptan benzoate 7.265mg equivalent to rizatriptan 5mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Matrix Laboratories Limited, Nashik, India
3579
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social WelfareMedicines, Consent, Distribution, Health
π₯ Approval of Cefuroxime-AFT (750mg)
π₯ Health & Social WelfareMedicine, Cefuroxime, AFT Pharmaceuticals, Injection
π₯ Approval of Cefuroxime-AFT (1500mg)
π₯ Health & Social WelfareMedicine, Cefuroxime, AFT Pharmaceuticals, Injection
π₯ Approval of Cipflox
π₯ Health & Social WelfareMedicine, Ciprofloxacin, Mylan, Infusion
π₯ Approval of Loperamide Relief
π₯ Health & Social WelfareMedicine, Loperamide, Mylan, Capsule
π₯ Approval of Nevirapine Alphapharm
π₯ Health & Social WelfareMedicine, Nevirapine, Mylan, Tablet
π₯ Approval of Noraped
π₯ Health & Social WelfareMedicine, Noradrenaline, Mylan, Infusion
π₯ Approval of Onglyza
π₯ Health & Social WelfareMedicine, Saxagliptin, AstraZeneca, Tablet
π₯ Approval of Pravastatin (10mg)
π₯ Health & Social WelfareMedicine, Pravastatin, REX Medical, Tablet
π₯ Approval of Pravastatin (20mg)
π₯ Health & Social WelfareMedicine, Pravastatin, REX Medical, Tablet
π₯ Approval of Pravastatin (40mg)
π₯ Health & Social WelfareMedicine, Pravastatin, REX Medical, Tablet
π₯ Approval of Rizamelt
π₯ Health & Social WelfareMedicine, Rizatriptan, Mylan, Orodispersible
NZ Gazette 2010, No 143